Evidence map›Paper›PMID 36930431›Full record

ReviewMycotoxin research2023

Hazard characterisation for significant mycotoxins in food.

Frantisek Malir, Darina Pickova, Jakub Toman, Yann Grosse, Vladimir Ostry

Abstract readReview
PubMed Publisher
In one paragraph

Review in Mycotoxin research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Phytochemical Profiling and Biological Activities ofPlants (Basel, Switzerland) · 2023
    Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Frantisek MalirDepartment of Biology, Faculty of Science, University of Hradec Kralove, Rokitanskeho 62, CZ-50003, Hradec Kralove, Czech Republic. frantisek.malir@uhk.cz.ORCID http://orcid.org/0000-0003-0232-9670
Darina PickovaDepartment of Biology, Faculty of Science, University of Hradec Kralove, Rokitanskeho 62, CZ-50003, Hradec Kralove, Czech Republic.
Jakub TomanDepartment of Biology, Faculty of Science, University of Hradec Kralove, Rokitanskeho 62, CZ-50003, Hradec Kralove, Czech Republic.
Yann GrosseThe IARC Monographs Programme, International Agency for Research On Cancer (retired), Lyon, France.
Vladimir OstryCenter for Health, Nutrition and Food in Brno, National Institute of Public Health, Palackeho 3a, 61242, Brno, Czech Republic.

Funding

World Health Organization 001
6 · The paper itself

Abstract

This review updates the current status of activities related to hazard characterisation for mycotoxins, with special reference to regulatory work accomplished within the European Union. Because the relevant information on these topics is widely scattered in the scientific literature, this review intends to provide a condensed overview on the most pertinent aspects. Human health risk assessment is a procedure to estimate the nature and potential for harmful effects of mycotoxins on human health due to exposure to them via contaminated food. This assessment involves hazard identification, hazard characterisation, exposure assessment, and risk characterisation. Mycotoxins covered in this review are aflatoxins, ochratoxin A, cyclopiazonic acid, citrinin, trichothecenes (deoxynivalenol, nivalenol, T-2, and HT-2 toxins), fumonisins, zearalenone, patulin, and ergot alkaloids. For mycotoxins with clear genotoxic/carcinogenic properties, the focus is on the margin of exposure approach. One of its goals is to document predictive characterisation of the human hazard, based on studies in animals using conditions of low exposure. For the other, non-genotoxic toxins, individual 'no adverse effect levels' have been established, but structural analogues or modified forms may still complicate assessment. During the process of hazard characterisation, each identified effect is assessed for human relevance. The estimation of a 'safe dose' is the hazard characterisation endpoint. The final aim of all of these activities is to establish a system, which is able to minimise and control the risk for the consumer from mycotoxins in food. Ongoing research on mycotoxins constantly comes up with new findings, which may have to be implemented into this system.

Indexed as

AflatoxinsErgot AlkaloidsFumonisinsMycotoxinsPatulinZearalenoneAnimalsFood ContaminationHumansAflatoxinsErgot AlkaloidsFumonisinsMycotoxinsPatulinZearalenoneFoodHazard characterisationHealth risk assessmentMycotoxinsTotal diet study

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.